Your browser doesn't support javascript.
loading
Dengue Virus (DENV) Neutralizing Antibody Kinetics in Children After Symptomatic Primary and Postprimary DENV Infection.
Clapham, Hannah E; Rodriguez-Barraquer, Isabel; Azman, Andrew S; Althouse, Benjamin M; Salje, Henrik; Gibbons, Robert V; Rothman, Alan L; Jarman, Richard G; Nisalak, Ananda; Thaisomboonsuk, Butsaya; Kalayanarooj, Siripen; Nimmannitya, Suchitra; Vaughn, David W; Green, Sharone; Yoon, In-Kyu; Cummings, Derek A T.
Afiliação
  • Clapham HE; Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, Maryland.
  • Rodriguez-Barraquer I; Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, Maryland.
  • Azman AS; Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, Maryland.
  • Althouse BM; Institute for Disease Modeling, Bellevue, Washington Santa Fe Institute, Las Cruces, New Mexico New Mexico State University, Las Cruces, New Mexico.
  • Salje H; Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, Maryland.
  • Gibbons RV; US Army Institute of Surgical Research, San Antonio, Texas.
  • Rothman AL; University of Rhode Island, Providence.
  • Jarman RG; Department of Virology, Armed Forces Research Institute of Medical Science.
  • Nisalak A; Department of Virology, Armed Forces Research Institute of Medical Science.
  • Thaisomboonsuk B; Department of Virology, Armed Forces Research Institute of Medical Science.
  • Kalayanarooj S; Queen Sirikit National Institute of Child Health, Bangkok, Thailand.
  • Nimmannitya S; Queen Sirikit National Institute of Child Health, Bangkok, Thailand.
  • Vaughn DW; Department of Virology, Armed Forces Research Institute of Medical Science.
  • Green S; Division of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester.
  • Yoon IK; Dengue Vaccine Initiative, International Vaccine Institute, Seoul, Korea.
  • Cummings DA; Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, Maryland Department of Biology, University of Florida, Gainesville Emerging Pathogens Institute, University of Florida, Gainesville.
J Infect Dis ; 213(9): 1428-35, 2016 May 01.
Article em En | MEDLINE | ID: mdl-26704615
ABSTRACT
The immune response to dengue virus (DENV) infection is complex and not fully understood. Using longitudinal data from 181 children with dengue in Thailand who were followed for up to 3 years, we describe neutralizing antibody kinetics following symptomatic DENV infection. We observed that antibody titers varied by serotype, homotypic vs heterotypic responses, and primary versus postprimary infections. The rates of change in antibody titers over time varied between primary and postprimary responses. For primary infections, titers increased from convalescence to 6 months. By comparing homotypic and heterotypic antibody titers, we saw an increase in type specificity from convalescence to 6 months for primary DENV3 infections but not primary DENV1 infections. In postprimary cases, there was a decrease in titers from convalescence up until 6 months after infection. Beginning 1 year after both primary and postprimary infections, there was evidence of increasing antibody titers, with greater increases in children with lower titers, suggesting that antibody titers were boosted due to infection and that higher levels of neutralizing antibody may be more likely to confer a sterilizing immune response. These findings may help to model virus transmission dynamics and provide baseline data to support the development of vaccines and therapeutics.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dengue / Vírus da Dengue / Anticorpos Neutralizantes / Anticorpos Antivirais Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dengue / Vírus da Dengue / Anticorpos Neutralizantes / Anticorpos Antivirais Idioma: En Ano de publicação: 2016 Tipo de documento: Article